Fungi drink development is one of the most exciting and technically demanding opportunities in the UK beverage market in 2025. Consumer awareness of functional mushrooms has crossed from niche wellness circles into mainstream health culture, and the brands ready to build commercially viable, well-formulated, and compliantly labelled fungi drinks are sitting at the edge of a significant market opportunity.
At Branding Innovations, we have spent 20 years developing functional drink brands from concept to commercial reality. We understand the specific formulation challenges, the complex regulatory landscape, and the commercial strategy required to build a fungi drink that genuinely earns its place on a retail shelf.
This guide gives you the complete picture of the market opportunity, the mushroom science, the regulatory status of every key species, the formulation challenges, and the commercial strategy that separates successful fungi drink brands from those that never make it past a crowdfunding page.
The numbers behind the functional mushroom market in 2025 are extraordinary, and they are accelerating.
The UK functional mushroom market reached USD 1.85 billion in 2024 and is expected to grow to around USD 4.42 billion by 2032, expanding at a CAGR of approximately 11.5% from 2025 to 2032. Consumer interest in cognitive enhancement, immune support, and stress management is driving rapid expansion across beverages, powders, and functional wellness stacks.
The global market for mushroom drinks was recently valued at USD 4.69 billion, with strong growth expected. These drinks are popular in gyms and cafes, offering benefits like immune support and better focus.
The mushroom-infused beverages market is growing at a CAGR of 21.20% during the forecast period of 2025 to 2033, with year-on-year growth at 19.40%.
UK and global fungi drink market overview 2025:
| Metric | Figure | Source |
| UK functional mushroom market (2024) | USD 1.85 billion | DataM Intelligence |
| UK market projected (2032) | USD 4.42 billion | DataM Intelligence |
| UK CAGR (2025–2032) | 11.5% | DataM Intelligence |
| Global mushroom drinks market (2025) | USD 4.69 billion | Industry Today |
| Global mushroom-infused beverage CAGR | 21.20% (2025–2033) | HTF Market Insights |
| Global medicinal mushroom market (2024) | USD 24.8 billion | DataM Intelligence |
| Global medicinal mushroom projected (2032) | USD 48.56 billion | DataM Intelligence |
| Reishi UK market share (2025) | 36.02% | Mordor Intelligence |
| Cordyceps CAGR (2025–2031) | 9.87% — fastest-growing species | Mordor Intelligence |
Sources: DataM Intelligence, Industry Today, HTF Market Insights, Mordor Intelligence, Future Market Insights, 2025
Functional food companies are innovating by adding varieties such as reishi, chaga, cordyceps, turkey tail, and lion’s mane into everyday products from coffee and tea to snack bars and fortified drinks, making health benefits more accessible and convenient. As consumers become more health-savvy and education about these ingredients grows, this trend is expected to accelerate.
Fungi drinks are beverages formulated with functional mushroom extracts or powders that deliver specific health and wellness benefits. They are distinct from culinary mushroom products; they use specific adaptogenic and medicinal mushroom species chosen for their bioactive compounds.
Functional mushrooms recognised for their adaptogenic properties, including reishi, chaga, cordyceps, lion’s mane, and shiitake, are being incorporated into various wellness routines. Blends of multiple mushroom varieties are common, offering a broader spectrum of health advantages.
The main fungi drink formats in the UK market in 2025:
Each format has specific formulation requirements, shelf-life challenges, and regulatory considerations. Understanding which format fits your brand concept, target consumer, and production capability is the first decision in fungi drink development.
Each mushroom species brings a distinct bioactive profile, benefit claim, and regulatory status. Understanding these differences is non-negotiable before formulation begins.
The most commercially prominent mushroom in the UK cognitive performance category. Lion’s mane contains hericenones and erinacines compounds associated with nerve growth factor (NGF) stimulation and cognitive support.
Lion’s mane demonstrates the complexity of novel food regulations. The fruiting body and aqueous extract powder are not considered novel, giving brands flexibility in product development. However, dehydrated mycelium powder is classified as novel and therefore requires authorisation. This differentiation means traditional preparations are generally acceptable, while newer mycelium-based products face additional regulatory hurdles.
Key benefit: Cognitive support, memory, focus, and potential neurogenesis support
Taste profile: Mild, slightly earthy — relatively easy to formulate with
Best format: Coffee blends, RTD cognitive drinks, morning routine shots
Reishi held 36.02% market share in 2025, reflecting its established position in traditional Chinese medicine and decades of clinical research validating its immunomodulatory and hepatoprotective effects.
Known as the “mushroom of immortality” in traditional practice. Reishi is prized for stress reduction, immune support, and sleep quality improvement. It is the most well-evidenced functional mushroom in terms of clinical research volume.
Reishi has a split regulatory status, similar to lion’s mane. The fruiting body preparations are generally acceptable under UK Novel Foods regulations, while mycelium-based extracts require additional regulatory review.
Key benefit: Stress management, immune support, sleep quality, relaxation
Taste profile: Intensely bitter and woody significant flavour masking required
Best format: Evening relaxation drinks, calm beverages, DTC blends
Cordyceps is expanding at 9.87% CAGR through 2031, outpacing reishi’s growth as sports nutrition and energy supplement applications broaden its consumer base beyond wellness purists. It is cultivated on grain substrates, offers higher cordycepin content than wild-harvested Cordyceps sinensis, making it a cost-effective and sustainable alternative.
Cordyceps is particularly associated with endurance, energy production, and athletic performance driven by its influence on adenosine triphosphate (ATP) synthesis.
Regulatory note: Turkey tail and cordyceps mushroom products are now being removed from UK shelves and cannot be legally sold as food or supplements due to a new crackdown by the Food Standards Agency reclassifying these mushrooms as novel foods. Any brand intending to use cordyceps must check the current FSA novel food status before proceeding.
Key benefit: Energy, endurance, athletic performance, oxygen utilisation
Best format: Sports hydration, pre-workout drinks, energy shots
Chaga is one of the most antioxidant-rich substances found in nature. It is commonly consumed as a tea or coffee alternative and has strong associations with immune support, anti-inflammatory properties, and gut health.
Chaga presents an interesting regulatory case in the UK. Generally accepted as not novel in traditional tea preparations, the regulatory status of certain chaga extracts is subject to ongoing review. Brands must verify current FSA guidance before finalising any formulation.
Key benefit: Antioxidant support, immunity, anti-inflammatory, gut health
Taste profile: Earthy, slightly vanilla-like — more approachable than reishi
Best format: Coffee alternative, RTD wellness drinks, immunity shots
Turkey tail contains polysaccharide-K (PSK) and polysaccharide-P (PSP), compounds that support immune function. It is also associated with gut microbiome health through its prebiotic properties.
Turkey tail products are now being removed from UK shelves and cannot be legally sold as food or supplements following the FSA’s novel food reclassification. Brands must not include turkey tail in any UK product until Novel Foods authorisation is obtained.
Shiitake is the most widely consumed culinary mushroom globally and has an established food history. It contains lentinan, a polysaccharide with immune-stimulating properties. Its established consumption history means it generally does not face Novel Foods hurdles in the UK.
The shiitake segment is predicted to hold a share of approximately 35.6% of the functional mushroom market in 2025, supported by its long history of culinary and medicinal use across East Asia.
Key benefit: Immune support, cardiovascular health, gut health
Best format: Broths, health teas, functional tonics
This is the section that separates successful fungi drink brands from those that face product withdrawal, FSA enforcement, and destroyed retailer relationships. The Novel Foods landscape for functional mushrooms in the UK in 2025 is complex, evolving, and consequential.
Several functional mushrooms, such as Lion’s Mane mycelium, Cordyceps militaris, and Agaricus blazei Murrill dehydrated mycelium powder, are classified as novel foods. The fruiting body has been consumed in the EU before May 15, 1997 and can be marketed without pre-market authorisation. Dehydrated mycelium powder is novel;l there is no history of significant mycelium consumption in the EU before 1997, and therefore authorisation is required under UK Novel Foods regulations.
| Mushroom Species | Fruiting Body Status | Mycelium Status | Key Implication |
| Lion’s Mane | Generally not novel | Novel — requires FSA authorisation | Use fruiting body extract only |
| Reishi | Generally not novel | Split status — check with FSA | Fruiting body extracts are safer |
| Chaga | Generally not novel | Under review | Verify current FSA guidance |
| Cordyceps militaris | Novel — FSA reclassification | Novel | Do not use without authorisation |
| Turkey Tail | Novel — FSA reclassification | Novel | Do not use without authorisation |
| Shiitake | Not novel — established food | Established | Clear for use |
| Maitake | Generally not novel | Check per extract type | Verify with FSA |
Enforcement action may be taken by Trading Standards, the FSA, or the MHRA, depending on the nature of the issue. This includes product recalls and market withdrawals for unsafe or non-compliant products, fines or prosecution for serious breaches, and closure of non-compliant businesses or online listings.
Every fungi drink brand must verify the current status of every mushroom ingredient against the Food Standards Agency Novel Foods catalogue and obtain specific regulatory advice before finalising any formulation. The landscape is actively changing in 2025.
Health claims: what you cannot say
Currently, no declaration of mushroom properties is authorised on labelling in the UK or EU. Mushroom-based supplements and functional drinks cannot make approved health claims for the mushrooms themselves under current EFSA regulations.
Unsubstantiated health claims threaten consumer trust. The regulatory framework means brands must communicate mushroom benefits through ingredient transparency, consumer education, and careful brand storytelling, not through claims on the label.
This is not a barrier to brand building. It is an invitation to communicate with honesty and intelligence — building consumer trust that advertising claims cannot create.
Fungi drink development is more technically complex than standard functional drink formulation. The challenges are specific to mushroom ingredients.
The method used to extract active compounds from mushroom fruiting bodies significantly affects potency, bioavailability, and taste profile.
Hot water extraction — the traditional method. Effective for extracting polysaccharides, including beta-glucans, the primary immune-supporting compounds in most functional mushrooms. Good bioavailability. Produces a dark, earthy liquid.
Alcohol (ethanol) extraction — more effective for extracting triterpenoids, the compounds associated with reishi’s stress-modulating properties. Less appropriate for beverage formulation without additional processing.
Dual extraction — combines both methods for a fuller spectrum extract. Higher potency, higher cost, more complex formulation requirements.
Standardised extracts — commercially produced extracts with declared beta-glucan percentages. Consistent, scalable, and formulation-friendly. The preferred format for RTD fungi drink production.
At Branding Innovations, our formulation team selects extraction methods based on the specific bioactive compounds required for the intended benefit claim, not on cost alone.
Functional mushrooms have challenging flavour profiles. Reishi is intensely bitter and woody. Chaga has a strong, earthy character. Even lion’s mane, the most flavour-friendly, has a distinctive mushroom note that requires management.
Expert flavour masking is non-negotiable for consumer acceptance. The approaches we use:
Antioxidant activity, gut health, and immune support are key consumer motivations for fungi drinks. But consumers only return for the taste. Getting this balance right, functional delivery plus genuine taste enjoyment, is what separates successful fungi drink brands from the many that achieve one but not the other.
Mushroom extracts present specific stability challenges in beverage formats. Beta-glucans can precipitate out of solution, creating sediment that alarms consumers. Triterpenoids can oxidise over time, reducing potency and altering taste. Some extraction products are sensitive to pH, heat treatment, and UV light exposure.
Solutions include:
A fungi drink that contains a symbolic amount of lion’s mane, 10mg per can, delivers no measurable benefit and deceives the consumer. Effective doses in clinical research are typically much higher:
| Mushroom | Evidence-Based Dose Range | Common Underdosed Range in Products |
| Lion’s mane | 500mg–3,000mg per serving | 50mg–100mg |
| Reishi | 1,000mg–5,000mg per serving | 100mg–200mg |
| Chaga | 500mg–2,000mg per serving | 50mg–150mg |
| Cordyceps | 1,000mg–3,000mg per serving | 100mg–250mg |
Getting dose efficacy right requires both the formulation expertise to achieve effective doses in a palatable drink and the honesty to communicate dosage transparently on the label. Consumer trust in this category is built on the brands that deliver what they promise and eroded by those that use mushrooms as a marketing device at sub-therapeutic doses.
Every fungi drink we develop at Branding Innovations starts with market research not ingredient enthusiasm. Dr. Lilla Bessenyei, our specialist in functional and wellness ingredients, maps the competitive landscape, identifies the specific consumer and occasion the brand will serve, and verifies the regulatory status of every intended ingredient before a single sample is made.
This stage prevents the most expensive mistake in fungi drink development: building a formulation around an ingredient that subsequently fails a Novel Foods check.
The specific mushroom species, the extraction method, and the extract standardisation are all determined at this stage based on the intended benefit, the target consumer, the flavour management strategy, and the regulatory status confirmed in Stage 1.
Product quality and variability in potency, purity, and sourcing can affect efficacy and consumer trust. Lack of standardisation, where dosage varies widely between brands and concentration is not always indicated, is a significant issue in the functional mushroom category.
We source standardised extracts from verified suppliers with consistent beta-glucan percentages and documented production methods. This is the foundation of a credible label claim.
Our recipe development team, led by Claire with 40 years of commercial formulation experience, develops multiple prototype iterations, testing for taste, mouthfeel, extract stability, and consumer acceptance at every round.
A 2-gram serving of lion’s mane provides powerful compounds rivalling multi-ingredient blends. This efficacy depends entirely on the quality of the extract and the bioavailability achieved through the formulation and processing method.
Each prototype is tested in the specific consumption context of the target occasion morning focus, evening relaxation, pre-workout because the same drink tastes and feels different depending on when and how it is consumed.
Pilot production validates the formula at commercial scale before a full production run is committed. Stability testing running samples through accelerated shelf-life conditions validates that extract potency, taste, and physical appearance are maintained across the full intended shelf life.
For RTD fungi drinks targeting a 12-month ambient shelf life, this testing phase takes 6 to 12 weeks. It cannot be shortened. A fungi drink whose beta-glucan content degrades to negligible levels by month four has failed regardless of how good it tastes on day one.
Every ingredient’s novel food status confirmed. Every label claim is checked against the retained EFSA health claims register. Allergen declarations verified. Caffeine labelling applied where relevant. Nutritional information calculated for UK labelling standards.
We submit Novel Foods queries to the Food Standards Agency at the formulation stage, not after production has begun.
New entrants into the functional beverage space in 2025 are focusing on mushroom-based drinks targeting flavour, low sugar, and nutritional benefit with blends powered by lion’s mane and other adaptogenic fungi designed to appeal beyond niche health circles and into mainstream functional drink demand.
The fungi drink brand must communicate three things simultaneously: what the mushroom is, what it does, and why the consumer should trust this specific brand’s formulation. Our brand development services build the visual identity, packaging design, and brand messaging that achieve all three clearly, credibly, and distinctively on shelf and on screen.
Finding a co-packer with experience handling functional mushroom extracts understanding their processing sensitivities and maintaining BRCGS certification is a specialist task. Our established co-packer network, built over 20 years of brand launches, gives founders direct access to vetted production partners.
Our buyer network of 6,500 direct contacts then gives the finished brand access to the retail buyers at Planet Organic, Whole Foods, Holland & Barrett, Ocado, and independent health retailers who are actively seeking credible fungi drink brand additions to their ranges.
DIRTEA launched curated wellness stack bundles combining mushroom coffee with powders targeted at lifestyle needs like focus, energy, relaxation, and beauty from within. This product framing shapes daily wellness routines and cross-product adoption, demonstrating how fungi drink brands can build habitual daily consumption across multiple consumer occasions.
The four primary consumer groups driving fungi drink adoption in the UK in 2025:
The Cognitive Performance Seeker — professionals, students, and creatives who want sustained focus and mental clarity without synthetic stimulants. Lion’s mane coffee is the natural entry format. They are label-literate, dose-conscious, and willing to pay a premium for transparency.
The Wellness Routiner — health-conscious consumers who have built a daily supplement and functional food routine. They are familiar with adaptogens, have likely tried ashwagandha and nootropic drinks, and are adding functional mushrooms as the next layer of their stack.
The Stress and Sleep Consumer — motivated primarily by stress management and sleep quality. Reishi in an evening relaxation drink is their format. They overlap significantly with the alcohol-free spirits consumer and the adaptogen drinks buyer.
The Immune Support Consumer — particularly prevalent post-COVID, with heightened awareness of gut health and systemic immunity. Chaga and shiitake-based drinks resonate here. Gut health claims overlap with the prebiotic and probiotic drinks consumer.
The brands driving the fungi drinks category in the UK in 2025 share a specific set of commercial characteristics.
| Brand Characteristic | Commercial Impact |
| Specific species declared on the front of the pack | Consumer education is built into the brand |
| Standardised extract percentages disclosed | Credibility signal to health-literate consumers |
| Dose-effective quantities per serving | Repeat purchase driven by genuine efficacy |
| Expert flavour work — genuinely enjoyable | Daily habit formation rather than reluctant consumption |
| Honest absence of health claims | Trust built through transparency, not promises |
| Clear occasion positioning | Ritual integration into daily wellness routine |
| Premium but justified pricing | Quality ingredient sourcing visible in the product |
Companies offering high-quality extracts and consumer education are well-positioned to capitalise on the momentum and expand their footprint in both established and emerging markets.
Realistic cost breakdown for fungi drink development in the UK in 2025:
| Development Stage | Low End | High End | Notes |
| Market research and concept validation | £2,000 | £8,000 | Includes regulatory ingredient screening |
| Species selection, extract sourcing, and testing | £2,000 | £6,000 | Standardised extract procurement |
| Recipe development and prototyping | £8,000 | £22,000 | Complex flavour masking increases cost |
| Pilot production and stability testing | £4,000 | £14,000 | Essential — particularly for RTD formats |
| Novel Foods regulatory assessment | £2,000 | £15,000+ | Per ingredient — cordyceps/turkey tail is currently blocked |
| Brand identity and packaging design | £8,000 | £25,000 | Do not underfund this stage |
| First production run | £20,000 | £60,000 | Format and volume dependent |
| Route to market and year-one marketing | £5,000 | £20,000 | PR, sampling, trade shows, health retail |
| Working capital reserve | £5,000 | £15,000 | Retailer payment terms create a cash gap |
| Total | £56,000 | £185,000+ |
The wide range reflects formulation and regulatory complexity. A lion’s mane coffee blend using fruiting body extract costs less to develop and approve than a multi-species synergistic blend involving novel extract formats.
It is the complete process of creating a commercially viable beverage formulated with functional mushroom extracts, covering market research, species selection, formulation, regulatory compliance, stability testing, branding, and route to market launch.
Lion’s mane fruiting body extract, reishi fruiting body extract, chaga, and shiitake are generally acceptable. Cordyceps and turkey tail have been reclassified as novel foods by the FSA and cannot currently be legally sold in UK products. Always verify the current status before finalising any formulation.
No specific mushroom health claims are approved under the EFSA retained register in the UK. Brands communicate through ingredient transparency, dosage disclosure, and consumer education, not on-pack health claims. Work with a regulatory specialist to ensure all label copy is compliant.
The fruiting body is the above-ground part of the mushroom generally not classified as novel and legally usable in UK products for most species. Mycelium is the root-like structure classified as novel for several species, including lion’s mane, requiring FSA authorisation before commercial use.
Typically,y 10 to 18 months from initial concept to retail-ready product. Novel Foods regulatory assessment adds significant time for certain species. Do not begin production until regulatory clearance is confirmed for every ingredient in the formulation.
Yes, we manage the complete journey. From species selection and regulatory screening through formulation, brand development, co-packer sourcing, and direct buyer introductions through our network of 6,500 contacts. Book a free consultation to discuss your concept.
The fungi drinks market in 2025 represents a genuinely extraordinary opportunity for brands willing to do the development work correctly. Consumer demand is real and accelerating. The science behind functional mushrooms is credible and growing. And the window for well-positioned challenger brands to establish dominant positions in specific mushroom-based benefit categories is right now.
But fungi drink development is not simple. The regulatory landscape is complex and actively changing. The formulation challenges, flavour masking, dose efficacy, bioavailability, and stability require genuine specialist expertise. And the brands that succeed are those that communicate with transparency and intelligence, not those that use mushrooms as a marketing layer over an underdosed, overclaimed product.
At Branding Innovations, we bring the complete expertise required to build a fungi drink brand that earns its place on a shelf 20 years of development experience, 40 years of formulation expertise, specialist functional ingredient knowledge from Dr. Lilla Bessenyei, and direct buyer access to over 6,500 contacts built over 20 years.
If you are ready to develop a fungi drink that genuinely delivers, book a free consultation with us today.
Richard Horwell is the Managing Director of Branding Innovations, a London-based functional drink development specialist. He has over 30 years of FMCG experience across the UK, USA, Australia, and the Middle East, and has been behind the development of more than 200 food and drink brands worldwide. For specialist guidance on product development and brand development, contact the Branding Innovations team today.